BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 1 Jun · 19:14 IST

Bliss GVS Pharma Limited has informed the Exchange regarding 'a copy of newspaper publication regarding the Detailed Public Statement in connection with the Open Offer made to the public shareholders of the Company'.

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.2%1-day move
₹402.40
prior close
₹398.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.7+2.2+2.5+3.3+9.2+12.7+8.8+4.7+4.7+8.8+16.7+30.6
Up moveDown movePending
AI summary

Bliss GVS Pharma has informed the stock exchange about the publication of a Detailed Public Statement in newspapers related to an Open Offer made to its public shareholders. This is a mandatory disclosure under SEBI Takeover Regulations, typically published after an acquirer announces its intention to buy shares from existing shareholders. The filing confirms compliance with the newspaper publication requirement for the open offer process. Shareholders should look out for the offer price, tendering dates, and the identity of the acquirer mentioned in the published statement.

Likely market impact

Public shareholders of Bliss GVS Pharma may have an option to tender their shares at the offer price specified in the open offer. Investors should review the detailed public statement carefully for offer price, open/close dates, and conditions before deciding to participate.